Kenvue Ribbon-Cutting Marks Official Opening of New Global Headquarters in Summit, New Jersey
Kenvue Inc. (NYSE: KVUE) has officially opened its new 290,000 sq. ft. global headquarters in Summit, New Jersey, relocating from Skillman. The facility includes a 100,000 sq. ft. state-of-the-art Science and Innovation Lab and features several specialized areas: The Insights Lab, Virtual Experience Room with 270-degree digital retail environment, Sensory Lab for rapid prototyping, Design Lab for 3D/2D modeling, and The Company Store.
The LEED Gold certified headquarters consolidates teams previously spread across seven U.S. locations, positioning itself near major talent hubs in life science, data, technology, and marketing. The maker of iconic brands like Neutrogena®, Listerine®, Aveeno®, and Tylenol® aims to foster innovation and enhance consumer experiences through this new facility.
Kenvue Inc. (NYSE: KVUE) ha ufficialmente aperto il suo nuovo quartier generale globale di 290.000 piedi quadrati a Summit, nel New Jersey, trasferendosi da Skillman. La struttura include un laboratorio di scienza e innovazione all'avanguardia di 100.000 piedi quadrati e presenta diverse aree specializzate: il Laboratorio Insights, la Sala Esperienza Virtuale con un ambiente di vendita digitale a 270 gradi, il Laboratorio Sensoriale per prototipazione rapida, il Laboratorio di Design per modellazione 3D/2D e il Negozio Aziendale.
Il quartier generale certificato LEED Gold consolida i team precedentemente distribuiti in sette sedi negli Stati Uniti, posizionandosi vicino ai principali hub di talenti nelle scienze della vita, nei dati, nella tecnologia e nel marketing. Il produttore di marchi iconici come Neutrogena®, Listerine®, Aveeno® e Tylenol® mira a promuovere l'innovazione e migliorare le esperienze dei consumatori attraverso questa nuova struttura.
Kenvue Inc. (NYSE: KVUE) ha inaugurado oficialmente su nueva sede global de 290,000 pies cuadrados en Summit, Nueva Jersey, trasladándose desde Skillman. La instalación incluye un laboratorio de Ciencia e Innovación de 100,000 pies cuadrados y cuenta con varias áreas especializadas: el Laboratorio de Insights, la Sala de Experiencia Virtual con un entorno de venta digital de 270 grados, el Laboratorio Sensorial para prototipado rápido, el Laboratorio de Diseño para modelado 3D/2D y la Tienda de la Compañía.
La sede certificada LEED Gold consolida equipos previamente distribuidos en siete ubicaciones en EE. UU., posicionándose cerca de los principales centros de talento en ciencias de la vida, datos, tecnología y marketing. El fabricante de marcas icónicas como Neutrogena®, Listerine®, Aveeno® y Tylenol® busca fomentar la innovación y mejorar las experiencias del consumidor a través de esta nueva instalación.
Kenvue Inc. (NYSE: KVUE)는 뉴저지주 서밋에 29만 평방피트 규모의 새로운 글로벌 본사를 공식 개소하였으며, 이는 스킬맨에서 이전한 것입니다. 이 시설에는 10만 평방피트 규모의 최첨단 과학 및 혁신 실험실이 포함되어 있으며, 여러 전문 영역을 갖추고 있습니다: 인사이트 실험실, 270도 디지털 소매 환경을 갖춘 가상 경험실, 신속 프로토타이핑을 위한 감각 실험실, 3D/2D 모델링을 위한 디자인 실험실, 그리고 회사 상점입니다.
이 LEED Gold 인증 본사는 이전에 미국 내 7개 위치에 분산되어 있던 팀을 통합하여 생명 과학, 데이터, 기술 및 마케팅의 주요 인재 허브 근처에 위치하고 있습니다. Neutrogena®, Listerine®, Aveeno®, Tylenol®와 같은 아이코닉 브랜드의 제조업체는 이 새로운 시설을 통해 혁신을 촉진하고 소비자 경험을 향상시키는 것을 목표로 하고 있습니다.
Kenvue Inc. (NYSE: KVUE) a officiellement ouvert son nouveau siège mondial de 290 000 pieds carrés à Summit, dans le New Jersey, après avoir déménagé de Skillman. L'établissement comprend un laboratoire de science et d'innovation de 100 000 pieds carrés à la pointe de la technologie et dispose de plusieurs zones spécialisées : le laboratoire Insights, la salle d'expérience virtuelle avec un environnement de vente numérique à 270 degrés, le laboratoire sensoriel pour le prototypage rapide, le laboratoire de design pour la modélisation 3D/2D et la boutique de l'entreprise.
Le siège certifié LEED Gold regroupe des équipes précédemment dispersées sur sept sites aux États-Unis, se positionnant à proximité des principaux pôles de talents dans les sciences de la vie, les données, la technologie et le marketing. Le fabricant de marques emblématiques telles que Neutrogena®, Listerine®, Aveeno® et Tylenol® vise à favoriser l'innovation et à améliorer l'expérience des consommateurs grâce à cette nouvelle installation.
Kenvue Inc. (NYSE: KVUE) hat offiziell seinen neuen globalen Hauptsitz mit einer Fläche von 290.000 Quadratfuß in Summit, New Jersey, eröffnet und ist von Skillman umgezogen. Die Einrichtung umfasst ein 100.000 Quadratfuß großes hochmodernes Wissenschafts- und Innovationslabor und verfügt über mehrere spezialisierte Bereiche: Das Insights-Labor, den virtuellen Erlebnisraum mit einer 270-Grad-Digitalverkaufsumgebung, das Sensorlabor für schnelle Prototypenerstellung, das Designlabor für 3D/2D-Modellierung und den Unternehmensladen.
Der LEED Gold zertifizierte Hauptsitz konsolidiert Teams, die zuvor auf sieben Standorte in den USA verteilt waren, und positioniert sich in der Nähe wichtiger Talentzentren in den Bereichen Lebenswissenschaften, Daten, Technologie und Marketing. Der Hersteller ikonischer Marken wie Neutrogena®, Listerine®, Aveeno® und Tylenol® zielt darauf ab, Innovationen zu fördern und das Verbrauchererlebnis durch diese neue Einrichtung zu verbessern.
- Consolidation of operations from 7 locations to improve operational efficiency
- Strategic location near major talent hubs for life science, data, technology, and marketing
- State-of-the-art facilities for product development and testing
- LEED Gold certification demonstrating environmental commitment
- None.
Maker of iconic brands such as Neutrogena®, Listerine®, Aveeno®, and Tylenol® embarks on new era at global headquarters in 2025

Kenvue Global Headquarters,
Locating its LEED Gold certified global headquarters in
- The Insights Lab, a high-tech, multi-room experience is designed to transform how Kenvue develops, tests, and showcases its products. The Virtual Experience Room immerses users in a 270-degree digital retail environment, allowing real-time feedback on in-store execution.
- The Sensory Lab enables rapid prototyping and consumer testing, ensuring products meet evolving consumer needs.
- The Design Lab brings human-centered design to life through advanced 3D and 2D modeling.
- At the heart of the headquarters, The Company Store offers a best-in-class shopping experience, turning every Kenvuer into a brand ambassador.
The new headquarters also provides the Company with proximity to exceptional talent across major areas, such as life science, data, technology, and marketing, which is crucial for a people-first company like Kenvue. Joined by
“There is no better place to unlock the full potential of our iconic brands than in the state many of our brands have proudly called home for more than 135 years,” said Thibaut Mongon, Chief Executive Officer, Kenvue. “Our thoughtfully designed campus, brings together our iconic brands and our people under one roof, allowing us to innovate, drive growth and realize the extraordinary power of everyday care for more people in
“I am thrilled to welcome Kenvue as they establish their home in
“Today marks a significant milestone for
For his part,
By combining the power of science with meaningful human insights and a digital-first approach, Kenvue is poised to lead the charge in redefining consumer health for the future with science-driven innovations for iconic brands such as Neutrogena®, Listerine®, Tylenol® and Aveeno® amplified by cutting-edge technology, sustainable design and state-of-the-art amenities.
About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the opening of Kenvue’s new global headquarters in
A list and descriptions of risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250319001486/en/
Melissa Witt
media@kenvue.com
Source: Kenvue